|Articles|June 1, 2003

Bucking the One-Time Trendsetter

San Francisco - According to an analysis of data from more than 700 patients, a new nonsteroid treatment for atopic dermatitis is a safe, effective, and cost-effective alternative to conventional therapy for the chronic, relapsing inflammatory skin disease that primarily affects infants and children.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME